The Role of Direct Oral Anticoagulants in Managing Myeloproliferative Neoplasms Patients
Despite the limitations of retrospective data, DOAC treatment in MPN patients seems effective and has an acceptable bleeding risk.
Authors
- Soo-Mee Bang
- W. D. Park
- Eun Hee Jung (ORCID: https://orcid.org/0000-0002-3057-4502)
- Koung Jin Suh (ORCID: https://orcid.org/0000-0002-1881-8738)
- Min-Su Kang (ORCID: https://orcid.org/0000-0001-6491-2277)
- Yu Jung Kim (ORCID: https://orcid.org/0000-0002-5037-0523)
- Jeongmin Seo (ORCID: https://orcid.org/0000-0002-1018-9009)
- Se Hyun Kim (ORCID: https://orcid.org/0000-0002-2292-906X)
- Keun‐Wook Lee (ORCID: https://orcid.org/0000-0002-8491-703X)
- Sang‐A Kim (ORCID: https://orcid.org/0000-0002-8529-0232)
- Jeong‐Ok Lee (ORCID: https://orcid.org/0000-0001-9402-6372)
- Ji‐Won Kim (ORCID: https://orcid.org/0000-0001-6426-9074)
- Jin Won Kim (ORCID: https://orcid.org/0000-0002-1357-7015)
- Ju Hyun Lee (ORCID: https://orcid.org/0000-0001-5743-6751)
- Ji Yun Lee (ORCID: https://orcid.org/0000-0002-5835-7219)
- Jee Hyun Kim
Institutions
- Seoul National University Bundang Hospital (KR)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2024-09-20
- DOI
- https://doi.org/10.4143/crt.2024.738
- Citations
- 3
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- Seoul National University Bundang Hospital
- Seoul National University